Pitt to Use WaferGen SmartChip in NIH-Supported Studies | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that the University of Pittsburgh will use its SmartChip Real-Time PCR System in genomics, gene expression, and disease studies that are funded by the National Institutes of Health.

The Pittsburgh researchers are using $350,000 of a $3.5 million American Recovery and Reinvestment Act grant to support their efforts. The award is partially funding two research programs conducted under a collaboration with Pittsburgh, Harvard University, Boston University, National Jewish Hospital, and Wake Forest University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.